Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Thermogenesis Holdings Inc THMO

Healthcare Medical Devices
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include... see more

Recent & Breaking News (NDAQ:THMO)

ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update

PR Newswire November 13, 2023

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

PR Newswire November 8, 2023

ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento

PR Newswire October 26, 2023

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

PR Newswire September 6, 2023

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

PR Newswire August 10, 2023

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

PR Newswire August 8, 2023

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

PR Newswire July 17, 2023

ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

PR Newswire May 15, 2023

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

PR Newswire May 10, 2023

ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update

PR Newswire March 30, 2023

ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update

PR Newswire March 28, 2023

THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

PR Newswire March 20, 2023

THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

PR Newswire March 16, 2023

ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies

PR Newswire March 15, 2023

ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire January 11, 2023

ThermoGenesis Announces 1-for-45 Reverse Stock Split

PR Newswire December 21, 2022

ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update

PR Newswire November 10, 2022

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update

PR Newswire November 7, 2022

THERMOGENESIS CLOSES $2.05 MILLION PUBLIC OFFERING

PR Newswire October 28, 2022

THERMOGENESIS PRICES $2.05 MILLION PUBLIC OFFERING

PR Newswire October 25, 2022